909 related articles for article (PubMed ID: 18957682)
1. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
3. The impact of HMG-CoA reductase therapy on serum PSA.
Mener DJ; Cambio A; Stoddard DG; Martin BA; Palapattu GS
Prostate; 2010 May; 70(6):608-15. PubMed ID: 19998369
[TBL] [Abstract][Full Text] [Related]
4. Re: The influence of statin medications on prostate-specific antigen levels.
Cicero AF; Derosa G; Gaddi AV
J Natl Cancer Inst; 2009 Apr; 101(8):610; author reply 610-1. PubMed ID: 19351921
[No Abstract] [Full Text] [Related]
5. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
6. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
Cyrus-David MS; Weinberg A; Thompson T; Kadmon D
J Urol; 2005 Jun; 173(6):1923-5. PubMed ID: 15879782
[TBL] [Abstract][Full Text] [Related]
7. Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males.
Khosropanah I; Falahatkar S; Farhat B; Heidari Bateni Z; Enshaei A; Allahkhah AA; Khosropanah D
Acta Med Iran; 2011; 49(12):789-94. PubMed ID: 22174166
[TBL] [Abstract][Full Text] [Related]
8. The association between statins and cancer incidence in a veterans population.
Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
[TBL] [Abstract][Full Text] [Related]
9. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
Fox KM; Gandhi SK; Ohsfeldt RL; Davidson MH
Am J Manag Care; 2007 Dec; 13 Suppl 10():S270-5. PubMed ID: 18095777
[TBL] [Abstract][Full Text] [Related]
10. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
11. Differences between statins on clinical endpoints: a population-based cohort study.
Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
[TBL] [Abstract][Full Text] [Related]
12. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer.
Moyad MA; Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Adamovich E
Urology; 2005 Dec; 66(6):1150-4. PubMed ID: 16360430
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma EM; Leeper NJ; Heidenreich PA
J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
[TBL] [Abstract][Full Text] [Related]
14. Statins and prostate cancer risk: a case-control study.
Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
[TBL] [Abstract][Full Text] [Related]
15. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
[TBL] [Abstract][Full Text] [Related]
16. The use over time of statins in coronary patients in an Italian tertiary referral center.
Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
Punglia RS; Cullen J; McLeod DG; Chen Y; D'Amico AV
Cancer; 2007 Nov; 110(9):1973-8. PubMed ID: 17886252
[TBL] [Abstract][Full Text] [Related]
18. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
[TBL] [Abstract][Full Text] [Related]
19. Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer.
Moyad MA; Merrick GS; Butler WM; Wallner KE; Galbreath RW; Butler EG; Allen ZA; Adamovich E
Urol Nurs; 2006 Aug; 26(4):298-303. PubMed ID: 16939047
[TBL] [Abstract][Full Text] [Related]
20. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.
Rosenson RS
Am Heart J; 2006 Mar; 151(3):556-63. PubMed ID: 16504615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
